SFRP2 modulates non‑small cell lung cancer A549�cell apoptosis and metastasis by regulating mitochondrial fission via Wnt pathways
Cited by 16
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
|Frontiers in Oncology|2021|125
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
|Cancer Immunology Immunotherapy|2020|73
Deacetyl Ganoderic Acid F Inhibits LPS-Induced Neural Inflammation via NF-κB Pathway Both In Vitro and In Vivo
|Nutrients|2019|57
Loss of PARP-1 attenuates diabetic arteriosclerotic calcification via Stat1/Runx2 axis
|Cell Death and Disease|2020|57